Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Motion Perception | 1 | 2019 | 407 | 0.520 |
Why?
|
| Pattern Recognition, Visual | 1 | 2019 | 831 | 0.450 |
Why?
|
| Visual Fields | 1 | 2019 | 1036 | 0.430 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 1329 | 0.430 |
Why?
|
| Mutagenesis | 1 | 2022 | 1275 | 0.320 |
Why?
|
| Ovarian Neoplasms | 5 | 2022 | 4754 | 0.300 |
Why?
|
| Nuclear Physics | 2 | 2014 | 77 | 0.250 |
Why?
|
| Mutation | 7 | 2022 | 29672 | 0.240 |
Why?
|
| Autistic Disorder | 1 | 2022 | 1125 | 0.230 |
Why?
|
| Gene Amplification | 2 | 2023 | 1072 | 0.200 |
Why?
|
| Oncogenes | 2 | 2023 | 1269 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2023 | 2022 | 0.180 |
Why?
|
| Estrogen Receptor alpha | 1 | 2023 | 580 | 0.170 |
Why?
|
| Platinum Compounds | 1 | 2019 | 98 | 0.170 |
Why?
|
| BRCA1 Protein | 2 | 2022 | 1114 | 0.160 |
Why?
|
| Translocation, Genetic | 1 | 2023 | 1419 | 0.150 |
Why?
|
| Deoxycytidine | 1 | 2021 | 818 | 0.150 |
Why?
|
| Neoplasms | 3 | 2021 | 20941 | 0.150 |
Why?
|
| Point Mutation | 1 | 2022 | 1633 | 0.150 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 427 | 0.140 |
Why?
|
| Genes, BRCA2 | 1 | 2019 | 612 | 0.140 |
Why?
|
| Likelihood Functions | 1 | 2019 | 1001 | 0.140 |
Why?
|
| Gene Regulatory Networks | 2 | 2021 | 1719 | 0.130 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 3643 | 0.130 |
Why?
|
| Genes, BRCA1 | 1 | 2019 | 773 | 0.130 |
Why?
|
| Visual Pathways | 1 | 2019 | 572 | 0.130 |
Why?
|
| Elementary Particles | 1 | 2014 | 53 | 0.120 |
Why?
|
| DNA Replication | 1 | 2021 | 1443 | 0.120 |
Why?
|
| Neutrons | 1 | 2014 | 75 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 2019 | 1775 | 0.120 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1667 | 0.120 |
Why?
|
| Aging | 1 | 2022 | 8530 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2022 | 12080 | 0.110 |
Why?
|
| Photic Stimulation | 1 | 2019 | 2036 | 0.110 |
Why?
|
| Models, Theoretical | 2 | 2014 | 3578 | 0.100 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2021 | 2937 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2021 | 2088 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2019 | 1329 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11324 | 0.090 |
Why?
|
| Genome, Human | 4 | 2023 | 4430 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8452 | 0.080 |
Why?
|
| Single-Cell Analysis | 3 | 2022 | 2150 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5171 | 0.070 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 1359 | 0.070 |
Why?
|
| Brain | 1 | 2022 | 25764 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2019 | 6163 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 12249 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2021 | 5457 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 20448 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 16630 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 9245 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 8918 | 0.050 |
Why?
|
| INDEL Mutation | 1 | 2022 | 271 | 0.050 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 95 | 0.050 |
Why?
|
| DNA Mutational Analysis | 2 | 2020 | 4257 | 0.050 |
Why?
|
| Humans | 14 | 2023 | 725187 | 0.050 |
Why?
|
| Isoxazoles | 1 | 2021 | 214 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 460 | 0.050 |
Why?
|
| Protein Binding | 1 | 2022 | 9469 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2023 | 603 | 0.040 |
Why?
|
| Algorithms | 1 | 2019 | 13765 | 0.040 |
Why?
|
| Indazoles | 1 | 2020 | 285 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2022 | 772 | 0.040 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2022 | 15420 | 0.040 |
Why?
|
| Time Factors | 1 | 2019 | 40186 | 0.040 |
Why?
|
| Interferons | 1 | 2020 | 688 | 0.040 |
Why?
|
| Genomic Instability | 1 | 2021 | 706 | 0.040 |
Why?
|
| Female | 8 | 2023 | 375449 | 0.040 |
Why?
|
| Estrogens | 1 | 2023 | 1559 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2021 | 707 | 0.030 |
Why?
|
| Pyrazines | 1 | 2021 | 1231 | 0.030 |
Why?
|
| Ovary | 1 | 2020 | 997 | 0.030 |
Why?
|
| Exons | 1 | 2021 | 2429 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2021 | 3593 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 12180 | 0.030 |
Why?
|
| Drug Monitoring | 1 | 2020 | 946 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2021 | 4758 | 0.030 |
Why?
|
| Cell Division | 1 | 2021 | 4604 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1945 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 2912 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2021 | 1802 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 6371 | 0.030 |
Why?
|
| Thermodynamics | 1 | 2014 | 591 | 0.030 |
Why?
|
| Heterozygote | 1 | 2019 | 2825 | 0.030 |
Why?
|
| Piperidines | 1 | 2020 | 1565 | 0.030 |
Why?
|
| Alleles | 1 | 2021 | 6952 | 0.020 |
Why?
|
| Computational Biology | 1 | 2021 | 3526 | 0.020 |
Why?
|
| Chromatin | 1 | 2021 | 2849 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 3335 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3596 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 4875 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4308 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 14769 | 0.020 |
Why?
|
| Macrophages | 1 | 2020 | 5689 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2021 | 10477 | 0.020 |
Why?
|
| Apoptosis | 1 | 2021 | 9756 | 0.020 |
Why?
|
| Neurons | 1 | 2022 | 9344 | 0.010 |
Why?
|
| Pregnancy | 1 | 2021 | 28145 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17354 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 51869 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 39918 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 57656 | 0.010 |
Why?
|
| Mice | 1 | 2021 | 80300 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2020 | 61761 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 168714 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 161486 | 0.000 |
Why?
|
| Middle Aged | 1 | 2020 | 212292 | 0.000 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(65)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_